Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-03-15 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 15, 2023, addressed to stock exchanges, informing them about the schedule of an analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an intimation of a meeting schedule, not a financial report or detailed presentation. The document length is only 1723 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no detailed analysis, and no mention of report attachments. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2023-03-15 English
Shareholders meeting
Regulatory Filings
2023-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 7, 2023, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of scheduled meetings and does not contain any financial data, report, or detailed presentation. The document length is only 1788 characters, which is quite short and fits the pattern of an announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of upcoming meetings rather than a report or transcript of the meetings themselves. The document length is short (1867 characters), and it does not contain financial data, management discussion, or detailed presentations. It is not a report but an announcement of scheduled investor meetings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure requirements for listed companies. The content is an announcement of a meeting schedule, not a report or transcript of the meeting itself. The document length is only 1722 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-02-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 23, 2023, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is purely an announcement of scheduled meetings with investors and analysts, with no financial data, report, or detailed presentation included. The document length is only 1796 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it fits best under the category of Investor Presentation announcements or related updates. However, since it is only an intimation of the schedule of meetings and not the presentation itself, it does not qualify as an Investor Presentation (IP). It is also not a Regulatory Filing (RNS) in the sense of compliance or certification, nor a Call Transcript (CT). The closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement about investor meetings under SEBI regulations, since no other category precisely matches a meeting schedule notice.
2023-02-23 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.